A viral phospholipase A2 is required for parvovirus infectivity.
about
Persistent viremia by a novel parvovirus in a slow loris (Nycticebus coucang) with diffuse histiocytic sarcomaPackaging capacity of adeno-associated virus serotypes: impact of larger genomes on infectivity and postentry steps.Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminusHuman bocavirus capsid structure: insights into the structural repertoire of the parvoviridaeDirected evolution of adeno-associated virus to an infectious respiratory virusAmdoparvoviruses in small mammals: expanding our understanding of parvovirus diversity, distribution, and pathologyRecombinant Lipases and Phospholipases and Their Use as Biocatalysts for Industrial ApplicationsRole of capsid proteins in parvoviruses infectionParvoviruses cause nuclear envelope breakdown by activating key enzymes of mitosisLearning from the Viral Journey: How to Enter Cells and How to Overcome Intracellular Barriers to Reach the NucleusAdeno-associated virus: from defective virus to effective vectorStructure of Penaeus stylirostris Densovirus, a Shrimp PathogenStructure of Bombyx mori Densovirus 1, a Silkworm PathogenThe Structure and Host Entry of an Invertebrate ParvovirusOncolytic parvoviruses: from basic virology to clinical applicationsNovel amdovirus in gray foxesDiscovery of parvovirus-related sequences in an unexpected broad range of animalsGermline viral "fossils" guide in silico reconstruction of a mid-Cenozoic era marsupial adeno-associated virusPLA2G16 represents a switch between entry and clearance of PicornaviridaeGreen fluorescent protein-tagged adeno-associated virus particles allow the study of cytosolic and nuclear trafficking.Early steps in cell infection by parvoviruses: host-specific differences in cell receptor binding but similar endosomal trafficking.Mutagenesis of adeno-associated virus type 2 capsid protein VP1 uncovers new roles for basic amino acids in trafficking and cell-specific transduction.Comparative analysis of adeno-associated virus capsid stability and dynamicsDetection of parvovirus B19 nucleic acids and expression of viral VP1/VP2 antigen in human colon carcinoma.Recombination and population mosaic of a multifunctional viral gene, adeno-associated virus cap.In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses.The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity.Structure and expression strategy of the genome of Culex pipiens densovirus, a mosquito densovirus with an ambisense organization.Neurotoxicity and other pharmacological activities of the snake venom phospholipase A2 OS2: the N-terminal region is more important than enzymatic activity.The role of nuclear localization signal in parvovirus life cycle.Complementary induction of immunogenic cell death by oncolytic parvovirus H-1PV and gemcitabine in pancreatic cancerDepletion of virion-associated divalent cations induces parvovirus minute virus of mice to eject its genome in a 3'-to-5' direction from an otherwise intact viral particle.Structure of adeno-associated virus type 4.Identification and nearly full-length genome characterization of novel porcine bocavirusesBinding site on the transferrin receptor for the parvovirus capsid and effects of altered affinity on cell uptake and infection.Gene expression analysis of potential genes and pathways involved in the pathogenic mechanisms of parvovirus B19 in human colorectal cancer.Antibody-mediated enhancement of parvovirus B19 uptake into endothelial cells mediated by a receptor for complement factor C1q.The Acheta domesticus densovirus, isolated from the European house cricket, has evolved an expression strategy unique among parvoviruses.Molecular characterization of the newly identified human parvovirus 4 in the family ParvoviridaeAdvances in human B19 erythrovirus biology
P2860
Q21131081-B61150DE-477B-4127-9026-32267090A656Q24533013-BA81E076-1D2D-4ED3-BB24-E01FF1DBE0ACQ24563214-B5C43666-6B7B-41D2-8AC4-E26D83D760C2Q24606666-56E3259D-9446-412B-B1D4-FDFEDBD5D1ABQ24649385-809C2999-C8CF-4A30-8F19-AA34156C6052Q26777216-8F2B275E-31C2-4532-946C-68FD47963D99Q26784203-FE3441C8-50BE-403A-AA85-52976FCF0E17Q26799552-216D8739-A7F8-4CCC-8253-95FC43B66111Q27332338-4D7D9892-7E15-461D-9DB5-AA19612E1773Q27488284-F6DC3DD3-D081-4450-9FD0-FC5A5670E542Q27498163-2D0BB07C-ADEF-40E5-A97E-8B76B8CF0862Q27664037-7C5084AF-0E66-46D1-8024-5916D7E91AB5Q27667140-D6C2383D-01AE-478F-9608-6CD2E8479486Q27679925-E4269FE2-B633-42D9-AC92-242A59CD0257Q28081685-617FBDBA-CA29-40C3-B5D6-274ADC2CDD6DQ28250479-3CFA8723-4D0A-4ECD-89C8-A045147D66F7Q28596222-EA29D7F8-9116-4A51-9F06-A236DFF430DDQ28596803-57E4CAF6-BAD1-48E0-BB89-574BE9FEA864Q28854602-54A395BA-D586-4BBB-92A6-EDE8F9014F56Q30476153-11C40082-65D7-47A1-8D44-28CE4842B11EQ30490592-7E9AAD1A-8748-4A71-884F-0B4240EAC99AQ30495947-B594C3C2-CC85-48CA-ACFB-AAA83D1F227FQ30557598-18F47814-C1EE-4B8B-A363-DE16E4FD4607Q33282774-4006B777-B45F-4137-A28E-24E9869843D7Q33320533-1B0C860B-A09A-458C-9235-40A2ADC20C16Q33327474-63985BB1-BCD0-48AC-AEED-DBB989EF4EA1Q33340668-BC9DC008-E26F-4598-A104-DAEDA9EAB1C9Q33433809-5D914427-6944-41BE-B15E-E2CCBCC8D442Q33552284-DB8D27C9-FA7A-41F6-85DC-40FD8B593569Q33564577-FFFE007C-D135-4A60-8821-04D223FE52E9Q33602876-26E0CE4F-B20A-405E-801E-C7BFA0B69C4CQ33614600-3F9BC97A-884D-447A-87CF-6D54A1FE5409Q33724158-F00B6952-2887-4820-B55C-52439C1B30BAQ33737733-0231D134-EDB7-45DC-93C2-4957F0803B31Q33826804-0C00C7D9-252F-4871-9FD3-340159C31B98Q33844073-A7BF217A-466E-40F5-A0D1-59FFA550066DQ33900233-415F1E0E-4F04-4556-BD99-D121D7000EDCQ33966764-5782F85C-916C-40F5-BB64-6ACE468986B4Q34063834-A30E7137-456C-4598-B201-C4C4C0D28304Q34120947-6A839208-28DB-433F-A108-6F81A6397580
P2860
A viral phospholipase A2 is required for parvovirus infectivity.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
A viral phospholipase A2 is required for parvovirus infectivity.
@ast
A viral phospholipase A2 is required for parvovirus infectivity.
@en
A viral phospholipase A2 is required for parvovirus infectivity.
@nl
type
label
A viral phospholipase A2 is required for parvovirus infectivity.
@ast
A viral phospholipase A2 is required for parvovirus infectivity.
@en
A viral phospholipase A2 is required for parvovirus infectivity.
@nl
prefLabel
A viral phospholipase A2 is required for parvovirus infectivity.
@ast
A viral phospholipase A2 is required for parvovirus infectivity.
@en
A viral phospholipase A2 is required for parvovirus infectivity.
@nl
P2093
P1433
P1476
A viral phospholipase A2 is required for parvovirus infectivity.
@en
P2093
M C Lacoste
P304
P356
10.1016/S1534-5807(01)00031-4
P407
P577
2001-08-01T00:00:00Z